Search Results

- Quantifying agonist pharmacology and biased agonism Class 3 - Antagonist pharmacology and binding assay the Optimization of Candidate Selection Lecture 1: The Eyes to See- The Importance of Pharmacologic Assays

clear expectations and deliverables to build trust and reduce delays • Align teams across roles—from assay Decisions—Not Delays I help turn great science into clear deliverables • Define program objectives and guide assay

To stay relevant in the next decade, it’s not about chasing the latest assay or tool.

His current work is mainly focused on screening and assay development to bridge the gap between in vitro

the human aGPCRs CD97/ADGRE5 and Latrophilin/ADGRL3 and tested in HEK293T cells using a luciferase assay Tobias Langenhan's group, where I currently manage a project to establish a drug screening assay for In addition, the platform was used to develop assays for high-throughput screening for challenging adhesion

There she researched the beta-2 adrenergic receptor and developed assays to investigate real-time activity

drug discovery with predictive molecular modeling that forecasts receptor behavior—before the first assay receptor-ligand interactions after the fact; they aim to forecast receptor behavior before the first assay

protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination of heterotrimeric G protein, small GTP-binding

protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination of heterotrimeric G protein, small GTP-binding

protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination of heterotrimeric G protein, small GTP-binding

protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination of heterotrimeric G protein, small GTP-binding

technologies in gene synthesis, DNA information storage, gene editing, and large-scale multiplexed assays

Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the first adenosine receptor binding assay

INSERM with a specific interest in G protein-coupled receptors by developing original BRET and TR-FRET assays

his work on bioluminescence resonance energy transfer (BRET) resulted in the development of screening assays

Her research focuses on the structure and function of GTP binding proteins and the molecular mechanisms

- Quantifying agonist pharmacology and biased agonism Class 3 - Antagonist pharmacology and binding assay the Optimization of Candidate Selection Lecture 1: The Eyes to See- The Importance of Pharmacologic Assays

, to exploit a Ric-8-based technology to purify recombinant G proteins and to use the G proteins in assays

his work on bioluminescence resonance energy transfer (BRET) resulted in the development of screening assays

This is the kind of advance that matters for anyone building tools, assays, or therapeutics around receptor GPCR Podcast Read full article Back when GPCR assays were performed with single channel pipettes, failure Michelle Halls still remembers pipetting one sample at a time, holding her breath to keep the assay alive To stay relevant in the next decade, it’s not about chasing the latest assay or tool. receptor-ligand interactions after the fact; they aim to forecast receptor behavior before the first assay

Badr recounted Badr's Journey, Multiplexing Assays, and Collaboration Badr shared his learning process Yamina emphasized the potential of multiplexing assays in expanding the scope of scientific exploration

I employ a multidisciplinary approach that combines molecular pharmacology, biochemical assays, and biophysical

Translate project strategy into clear decision-driving assays Eliminate “nice to have” tests that stall

Eric Trinquet —how structured play turns into assays and why serendipity belongs in your build process

for receptor activator and continuously work to identify novel chemical modulators of AGPCRs through assay I have previous work experience at two separate contract research organizations centered on assay development

predict invasive potential of a luminal breast carcinoma we will (a) determine, via loss-of-function assays on ADGRL3, where I conducted research involving mammalian cell cultures and techniques such as BRET assays and gene expression assays.

This is the kind of advance that matters for anyone building tools, assays, or therapeutics around receptor

the Forefront of GPCR Drug Discovery Gain insider methods from the pioneers shaping biased signaling, assay Pharmechanics GPCR signaling & biased agonism expert regularly consulted by top pharma companies for assay Weekly GPCR Insights (papers, jobs, events) Networking with a global scientist community One failed assay

In this AMA session, you’ll learn how to: Decode GPCR signaling complexity using functional assay strategies #GPCR #DrGPCR #Pharmacology #DrugDiscovery #Biotech #AllostericModulation #Kinetics #AssayDevelopment

research focuses on elucidating the molecular basis of membrane protein signalling using quantitative assays